{"id":"W4396804144","doi":"10.1097/mnm.0000000000001858","title":"A phase 2, single-arm trial evaluating 131I-PSMA-1095 targeted radioligand therapy for metastatic castration-resistant prostate cancer","year":2024,"lang":"en","type":"article","venue":"Nuclear Medicine Communications","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Prostate cancer; Tolerability; Clinical endpoint; Internal medicine; Adverse effect; Oncology; Enzalutamide; Phases of clinical research; Urology; Cancer; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001984542,0.00221033,0.001955598,0.0005716234,0.000397133,0.0008811241,0.0009909685,0.001718399,0.004637081],"category_scores_gemma":[0.001232547,0.0005913072,0.001038679,0.0003470863,0.0009857852,0.0008672278,0.0003576253,0.002609837,0.0009404093],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008469837,"about_ca_system_score_gemma":0.001590093,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000696218,"about_ca_topic_score_gemma":0.00138941,"domain_scores_codex":[0.9995244,0.0002398045,0.00001927136,0.00008954227,0.00004392304,0.00008300393],"domain_scores_gemma":[0.9992179,0.0001485708,0.0001483565,0.00005787475,0.00004232907,0.0003851319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8464382,0.06477697,0.003419837,0.0008864332,0.000847769,0.0003804896,0.0002373656,0.002249369,0.03182912,0.0002813239,0.002690743,0.04596241],"study_design_scores_gemma":[0.682257,0.3113928,0.002926172,0.00002052165,0.0001512406,0.0001439916,0.00001918457,0.0008071664,0.001333783,0.0001164318,0.0008130372,0.00001875366],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930245,0.001106384,0.0005103205,0.0003737712,0.0001332492,0.00319369,0.000565109,0.00009541864,0.0009974211],"genre_scores_gemma":[0.9859102,0.001068444,0.001934623,0.001058958,0.0002702681,0.004996916,0.002000614,0.00003138097,0.002728541],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004637081,"threshold_uncertainty_score":0.01551265,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2433899594419136,"score_gpt":0.4876039271628204,"score_spread":0.2442139677209067,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}